index.php

Index • Roche Media News

Link: Roche Media News

    The latest media news from Roche
  1  2  3  4  5  6  7  8  9  10  next

Data from the coBRIM study will be presented at an upcoming medical meeting. Roche plans to submit t ... more

Data showed that over 90 percent of Japanese people in the study responded to treatment with alectin ... more

Acquisition of Phase I program offers a potential new approach for hormone receptor-positive breast ... more

Roche announced today the launch of cobas 6500, a fully automated urine testing system that consists ... more

Roche announced today that the EU Committee for Medicinal Products for Human Use (CHMP) recommended ... more

The U.S. Food and Drug Administration (FDA) has granted first Breakthrough Therapy Designation in bl ... more

Roche today announced that the EU Committee for Medicinal Products for Human Use (CHMP) recommended ... more

Roche announced today that the subcutaneous formulation of RoACTEMRA (tocilizumab) has received appr ... more

Roche announced today that the U.S. Food and Drug Administration (FDA) approved the cobas HPV (Human ... more

Roche announced today that the European Commission (EC) has approved a new subcutaneous (SC) formula ... more

Roche today announced that the U.S. Food and Drug Administration (FDA) approved Xolair (omalizumab) ... more

Roche announced today that the U.S. Food and Drug Administration (FDA) Microbiology Devices Panel of ... more

Diagnostics division strengthens its position in the serology market and expands its immunoassay por ... more

New data show lebrikizumab appears most effective in a specific sub-population of patients with high ... more

Roche announced today the launch of the fully automated CINtec PLUS cytology test to improve the det ... more

Roche announced today that the EU Committee for Medicinal Products for Human Use (CHMP) recommended ... more

Roche announced today that the subcutaneous formulation of RoACTEMRA (tocilizumab) has received a po ... more

Roche today announced that the U.S. Food and Drug Administration (FDA) approved Gazyva (obinutuzumab ... more

Roche today announced that the U.S. Food and Drug Administration (FDA) has approved a subcutaneous f ... more

Investment to help meet rising demand for licensed biologics and expected pipeline growth. ... more

Roche inaugurates Translational and Clinical Research Center at the Alexandria Center for Life Scien ... more

Roche today announced that the United States (U.S.) Food and Drug Administration (FDA) granted accel ... more

- New injectable administration takes two to five minutes, rather than 30 to 90 minutes with the cur ... more

Roche and Ascletis announced today that they have entered into a collaboration to develop and commer ... more

Roche announced today that the European Union #8217;s Committee for Medicinal Products for Human Use ... more

Roche, today announced that the Committee for Medicinal Products for Human Use (CHMP) has recommende ... more

Roche announced today the acquisition of PVT Probenverteiltechnik GmbH based in Waiblingen, Germany ... more

Roche announced today that STAGE, a Phase III trial evaluating ocrelizumab as a treatment for seropo ... more

Roche announced the winners of its global 3Rs Award Program - a unique and innovative program that h ... more

New data presented today showed that, for the first time, doctors can predict which hepatitis B pati ... more

Genentech, Inc. (NYSE: DNA), GlycArt, a company wholly-owned by Roche, and Roche (SWX: ROG) have ent ... more

Roche today announced that the U.S. Food and Drug Administration (FDA) has issued a complete respons ... more

Roche announced today that the European Commission has approved a shortened, 16-week course of treat ... more

  1  2  3  4  5  6  7  8  9  10  next